drugset

drugset / Trial / NCT05454098

Clifutinib Food Effect Study in Healthy Subjects

NCT05454098 ↗

Phase 1 Completed 40 enrolled Sunshine Lake Pharma Co., Ltd.

Non-randomizedParallel-groupOpen-labelOther

Summary

The purpose of this study is to evaluate to determine the effect of food on the PK of a single dose of 40 mg Clifutinib in healthy subjects.

Timeline

Start: 2022-11-08
Primary completion: 2022-12-08
Completion: 2022-12-08

Publications

Wang D, Wu M, Li X, Jiang Y, Liu B, Zhang Y, Deng L, Ding Y. A phase I study of HEC73543, an oral FLT3 inhibitor: the effect of food on pharmacokinetics after oral dosing in healthy Chinese volunteers. Front Pharmacol. 2025 Oct 8;16:1636504. doi: 10.3389/fphar.2025.1636504. eCollection 2025.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Clifutinib	Unknown	40 mg	Oral

Indications